Patent · US Active

Extended-release formulation for reducing the frequency of urination and method of use thereof

US8685453B2 · kind B2 · utility

1Cited by
1References
16Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 20, 2013
Grant dateApr 1, 2014
Priority date
Expiry dateMar 20, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising an analgesic agent formulated in an extended-release formulation. Another method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising multiple active ingredients formulated for extended-release. Yet another method comprises administering to a subject in need thereof an effective amount of a diuretic followed with another administration of a pharmaceutical composition comprising an analgesic agent formulated for extended-release.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.